A comparative study of treatment of cervical low-grade squamous intraepithelial lesions (LSIL)

Photodiagnosis Photodyn Ther. 2024 Feb:45:103920. doi: 10.1016/j.pdpdt.2023.103920. Epub 2023 Dec 2.

Abstract

Background and aims: Low-grade squamous intraepithelial lesion (LSIL) is one of two categories of cervical intraepithelial lesions. Given that controversy exists regarding its management, this comparative study aimed to evaluate the effect of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in treating LSIL of the high-risk human papillomavirus (HR-HPV)-infected cervix.

Methods: A total of 218 patients (25-45 years old) with cervical LSIL associated with HR-HPV who underwent ALA-PDT, loop electrosurgical excision procedure (LEEP), or observation only were included. The clearance rates of cervical LSIL and HR-HPV between the ALA-PDT, LEEP, and observation groups were compared at 6 and 12 months follow-up. Adverse reactions were also compared. The factors affecting the clearance on ALA-PDT of cervical LSIL were evaluated.

Results: There were no statistically significant differences in lesion and HR-HPV clearance rates between the ALA-PDT and LEEP groups at 6 and 12 months. However, the lesion and HR-HPV clearance rates were significantly higher in the ALA-PDT group than that in the observation group. The adverse reaction rate was significantly lower in the ALA-PDT group than in the LEEP group.

Conclusion: For patients with cervical LSIL, the lesion and HR-HPV clearance rates after ALA-PDT were close to those after LEEP and significantly higher than in the observation group. Moreover, the adverse reaction rate for ALA-PDT was much lower than that for LEEP. Therefore, ALA-PDT provides a new option for the minimally invasive treatment of cervical LSIL.

Keywords: 5-Aminolevulinic acid; High-risk human papillomavirus; Loop electrosurgical excision procedure; Low-grade squamous intraepithelial lesion; Photodynamic therapy.

MeSH terms

  • Adult
  • Aminolevulinic Acid / therapeutic use
  • Cervix Uteri
  • Female
  • Humans
  • Middle Aged
  • Papillomavirus Infections* / drug therapy
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Squamous Intraepithelial Lesions*

Substances

  • Photosensitizing Agents
  • Aminolevulinic Acid